Depletion of alloreactive T cells for tolerance induction in a recipient of kidney and hematopoietic stem cell transplantations

Pediatric Transplantation
Kanchana TangnararatchakitSuradej Hongeng

Abstract

The present case report represents a successful attempt to induce transplantation tolerance to organ allograft by combined administration of donor hematopoietic cells and kidney based on in vivo deletion of alloreactive host-vs-graft and graft-vs-host alloreactive T cells following non-myeloablative conditioning. We were able to induce mixed and eventually full donor chimerism and tolerance of kidney allograft in a 15-yr-old male with ESRD after cisplatin treatment and autologous HSCT for mediastinal germ cell tumor. Our approach to induce tolerance was based on preferential depletion of alloreactive T cells induced by exposure to donor's alloantigens and administration of cyclophosphamide at day 2 and day 3 after stem cell infusion. Additional non-specific immunosuppression as part of the conditioning included exposure to two fractions of TLI, treatment with alemtuzumab (monoclonal anti-CD52) and short-term conventional IS treatment to avoid early graft loss, because of request of IRB. Using this approach, with rapid tapering of all conventional IS treatment, the patient maintains good renal functions without evidence of both acute and chronic rejection for 32 months off all medications.

References

Jan 1, 1988·Immunology Today·M Sykes, D H Sachs
Feb 1, 1981·Annals of Surgery·R J HowardJ S Najarian
Dec 1, 1996·Immunology Today·T E StarzlA S Rao
Oct 3, 1953·Nature·R E BILLINGHAMP B MEDAWAR
Apr 13, 2004·Transplantation·A Benedict Cosimi, David H Sachs
Jan 25, 2008·The New England Journal of Medicine·Tatsuo KawaiDavid H Sachs
Jan 25, 2008·The New England Journal of Medicine·John D ScandlingSamuel Strober
Jan 25, 2008·The New England Journal of Medicine·Stephen I AlexanderMichael O Stormon
May 21, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Leo LuznikEphraim J Fuchs
Sep 3, 2010·Nature Reviews. Nephrology·Nina Pilat, Thomas Wekerle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
J A Bradley
Proceedings of the National Academy of Sciences of the United States of America
R D OwenL G Baldwin
© 2021 Meta ULC. All rights reserved